Literature DB >> 3967632

Development of a standard protocol for in vitro cytogenetic testing with Chinese hamster ovary cells: comparison of results for 22 compounds in two laboratories.

S M Galloway, A D Bloom, M Resnick, B H Margolin, F Nakamura, P Archer, E Zeiger.   

Abstract

A major problem of cytogenetics testing in mammalian cells is lack of agreement of results among laboratories. Our objective was to develop a sensitive in vitro test protocol that was applicable to large-scale chemical screening and yielded comparable results in two laboratories. We used sister chromatid exchange (SCE) and chromosome aberration (CAb) tests in Chinese hamster ovary (CHO) cells. The initial protocol used standard cell densities, medium, batch of rat liver S9 for metabolic activation; positive, negative, and solvent controls; staining and scoring techniques; and fixation times. Treatment without S9 was for 8-12 hr (CAb) or 26 hr (SCE), and with S9 for 2 hr in serum-free medium. Bromodeoxyuridine (BrdUrd) (10 microM) was added to SCE cultures only, 2 hr after addition of the test chemical. Doses were based on the 50% toxicity level in a preliminary test of cell survival 24 hr after treatment. One hundred cells (CAb) or 50 cells (SCE) were scored from each control and from five dose levels. Five clastogens were tested in the first two-laboratory comparison: mitomycin-C, triethylenemelamine, N-methyl-N'-nitro-N-nitrosoguanidine, cyclophosphamide, and benzo(alpha)pyrene. There was quite good agreement between laboratories. Seventeen compounds were then tested "blind" in the two laboratories. As testing proceeded, some discrepancies occurred between the laboratories, and the protocol was modified in attempts to improve the resolution of marginal responses and make dose selection more consistent. The preliminary test for cell survival was omitted. A 10(5) dose range in a half-log series was tested, and cells were scored at the highest dose at which sufficient mitotic cells were obtained, and at the next two lower doses. By delaying fixation times, SCE and CAb were scored at doses that inhibited cell cycle progression. This protocol gave comparable results in the two laboratories in many cases and by testing up to a maximum dose, limited by solubility and/or toxicity, should detect a high proportion of clastogens and SCE inducers.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 3967632     DOI: 10.1002/em.2860070102

Source DB:  PubMed          Journal:  Environ Mutagen        ISSN: 0192-2521


  17 in total

1.  Ability of 13 chemical agents used in dental practice to induce sister-chromatid exchanges in Syrian hamster embryo cells.

Authors:  Takashi Miyachi; Takeki Tsutsui
Journal:  Odontology       Date:  2005-09       Impact factor: 2.634

Review 2.  High-throughput sequencing in mutation detection: A new generation of genotoxicity tests?

Authors:  Alexander Y Maslov; Wilber Quispe-Tintaya; Tatyana Gorbacheva; Ryan R White; Jan Vijg
Journal:  Mutat Res       Date:  2015-04-20       Impact factor: 2.433

3.  In vitro genotoxicity of chlorinated drinking water processed from humus-rich surface water.

Authors:  A Liimatainen; T Grummt
Journal:  Bull Environ Contam Toxicol       Date:  1988-11       Impact factor: 2.151

4.  17α-alkynyl 3α, 17β-androstanediol non-clinical and clinical pharmacology, pharmacokinetics and metabolism.

Authors:  Clarence Ahlem; Michael Kennedy; Theodore Page; David Bell; Evelyn Delorme; Sonia Villegas; Chris Reading; Steven White; Dwight Stickney; James Frincke
Journal:  Invest New Drugs       Date:  2010-09-03       Impact factor: 3.850

5.  Examination of cell toxicity and dosing regimen in an in vitro chromosomal aberration assay.

Authors:  V A Linscombe; K M Bodner; B B Gollapudi; A K Sinha
Journal:  In Vitro Cell Dev Biol Anim       Date:  1993-05       Impact factor: 2.416

6.  Studies of the pharmacology of 17α-ethynyl-androst-5-ene-3β,7β,17β-triol, a synthetic anti-inflammatory androstene.

Authors:  Clarence N Ahlem; Michael R Kennedy; Theodore M Page; Christopher L Reading; Steven K White; John J McKenzie; Phaedra I Cole; Dwight R Stickney; James M Frincke
Journal:  Int J Clin Exp Med       Date:  2011-04-23

7.  Genotoxicity of the cancer chemopreventive drug candidates CP-31398, SHetA2, and phospho-ibuprofen.

Authors:  Rupa S Doppalapudi; Edward S Riccio; Zoe Davis; Sean Menda; Abraham Wang; Nicholas Du; Carol Green; Levy Kopelovich; Chinthalapally V Rao; Doris M Benbrook; Izet M Kapetanovic
Journal:  Mutat Res       Date:  2012-04-10       Impact factor: 2.433

8.  Dose-dependent efficacy and safety toxicology of hydroxypyridinonate actinide decorporation agents in rodents: towards a safe and effective human dosing regimen.

Authors:  Deborah I Bunin; Polly Y Chang; Rupa S Doppalapudi; Edward S Riccio; Dahlia An; Erin E Jarvis; Birgitta Kullgren; Rebecca J Abergel
Journal:  Radiat Res       Date:  2013-01-04       Impact factor: 2.841

9.  Assessment of in vitro cytotoxic and genotoxic activities of some trimethoprim conjugates.

Authors:  Devrim Güzel Bayülken; R Beklem Bostancıoğlu; A Tansu Koparal; Berrin Ayaz Tüylü; Aydan Dağ; Kadriye Benkli
Journal:  Cytotechnology       Date:  2018-01-15       Impact factor: 2.058

10.  Formaldehyde-induced sister chromatid exchanges in vitro and the influence of the exogenous metabolizing systems S9 mix and primary rat hepatocytes.

Authors:  A Basler; W v d Hude; M Scheutwinkel-Reich
Journal:  Arch Toxicol       Date:  1985-10       Impact factor: 5.153

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.